Singapore Clinical Trial Market Sales Revenue Opportunity Report

Singapore has off late come to become the nucleus of clinical research activities in the Asia-Pacific region. The country is a natural hub for manufacturers and clinicians. It also possesses one of the best healthcare infrastructure networks in the entire region. Singapore is the third largest market in Asia for conducting clinical trials. The national government has been extremely supportive in developing clinical research activities and maintaining high immunization rates. The Singapore government in recent years has invested approximately USD1.1 billion into vaccine, translational and biomarker research. Additionally, the stringent intellectual-property laws and good clinical practice (GCP) guidelines is a significant source of security and assurance to the clients in the pharmaceuticals industry. Thus, the country is seen to have a great potential to capture the growth of the clinical trials industry not merely due to its strategic location, but also owing to its reputation of having a strong regulation in the biotech and pharmaceutical markets.

Download Report:

https://www.kuickresearch.com/report-Singapore-Clinical-Trial-Market-Analysis.php

For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990

"Singapore Clinical Trial Market Analysis" Table of Contents


1. Singapore Clinical Trial Market Overview
1.1 Market Overview
1.1.1 Clinical Trial by Phase
1.1.2 Clinical Trial by Therapeutic Area
1.2 Favorable Market Dynamics
1.3 Challenges to be Resolved

2. Disease Prevalence in Singapore

3. Patient Recruitment & Cost Analysis

4. Regulatory Framework to Conduct Clinical Trial
4.1 Certificate for Initiating Clinical Trial
4.2 Certificate for Import of Test Materials
4.3 Procedure for Advertisement/Recruitment Programme
4.4 Procedure for Extension of Clinical Trial Certificate
4.5 Good Clinical Practice Inspection Framework
4.6 Product Management for Investigator-Initiated Clinical Trials
4.7 Procedure for Enrollment of Unconscious/Mentally Incompetent Subjects
4.8 Investigational Product Repackaging

5. Competitive Landscape
5.1 Singapore Clinical Research Institute
5.2 CPR Pharma Services
5.3 Chiltern
5.4 ICON Clinical Research
5.5 Clinical Research Unit - Tan Tock Seng Hospital
5.6 Pacific Clinical Research
5.7 Department of Clinical Research – Singapore General Hospital
5.8 PPD

Figure 1-1: Share of Singapore in Global Clinical Trial Market
Figure 1-2: Clinical Trial Market (US$ Million), 2009-2018
Figure 1-3: Number of Certified Clinical Trials, 2009-2013
Figure 1-4: Number of Certified Clinical Trials by Phase, 2009-2013
Figure 1-5: Certified Clinical Trials by Phase (%), 2009-2013
Figure 1-6: Clinical Trial Market by Therapy (%), 2012 & 2013
Figure 1-7: Factor Driving Clinical Trial Market
Figure 1-8: Market Challenges to be Resolved
Figure 2-1: Share of Communicable & Non Communicable in Death Cause (%), 2012
Figure 2-2: Death Cause by Disease (%), 2011

List of Tables

Table 1-1: Number of Doctors, 2010-2012
Table 1-2: Number of Nurses, 2010-2012
Table 1-3: Number of Doctors by Specialty, 2010-2012
Table 3-1: Demographic Profile, 2010-2012

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
Avanta Business Center 4th Floor,
Statesman House Barakhamba Road,
Connaught Place New Delhi – 110 001, India
+91-11-47067990

This release was published on openPR.